People | December 02, 2023
AstraZeneca Pharma appoints Venkat Natarajan as Lead - Market Access
Currently, Venkat is Lead – Market Access, India at Pfizer
Currently, Venkat is Lead – Market Access, India at Pfizer
These regulatory approvals signify a significant milestone for Venus Remedies Limited
The company has raised US$4.5 million in funding for its AI operating system
European operations' revenue grew 58.4% to Rs 599.7 crore
US business grew by +12.8% YoY
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
Subscribe To Our Newsletter & Stay Updated
